PCMC
FLGT icon

Planning Capital Management Corporation’s Fulgent Genetics FLGT Stock Holding History

Planning Capital Management Corporation’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-616
Closed -$12.1K – 840
2024
Q2 		$12.1K Hold
616
– – 0.01% 383
2024
Q1 		$13.4K Hold
616
– – 0.01% 371
2023
Q4 		$17.8K Buy
+616
New +$16.5K 0.01% 317

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Planning Capital Management Corporation's FLGT Position: Q3 2024 in Review

Planning Capital Management Corporation sold out of Fulgent Genetics (FLGT) in Q3 2024, closing a stake of 616 shares — an estimated $12.1K sold.

Planning Capital Management Corporation first reported a position in FLGT in Q4 2023 and held it in 3 quarters. The position peaked at $17.8K in Q4 2023. 183 funds tracked by Wall St. Rank hold FLGT as of Q3 2024.

  • Planning Capital Management Corporation reported no remaining Fulgent Genetics position as of Q3 2024 after selling out during the quarter.
  • Planning Capital Management Corporation sold 616 Fulgent Genetics shares in Q3 2024, an estimated $12.1K.
  • Planning Capital Management Corporation first reported a position in Fulgent Genetics in Q4 2023 and held it in 3 quarters.
  • Planning Capital Management Corporation's Fulgent Genetics position peaked at $17.8K in Q4 2023.
  • 183 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.